852391-20-9,MFCD26960959
Catalog No.:AA00G3ML

852391-20-9 | Necrostatin 2 S-Enantiomer

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
99%
1 week  
$162.00   $113.00
- +
5mg
99%
1 week  
$352.00   $247.00
- +
10mg
99%
1 week  
$543.00   $380.00
- +
50mg
99%
1 week  
$1,320.00   $924.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00G3ML
Chemical Name:
Necrostatin 2 S-Enantiomer
CAS Number:
852391-20-9
Molecular Formula:
C13H12ClN3O2
Molecular Weight:
277.7063
MDL Number:
MFCD26960959
SMILES:
CN1C(=O)[C@@H](NC1=O)Cc1c[nH]c2c1cccc2Cl
Properties
Computed Properties
 
Complexity:
403  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.9  

Literature

Title: Structure-activity relationship study of novel necroptosis inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20051115

Title: Teng X, Keys H, Jeevanandam A, Structure-activity relationship study of ,2,3thiadiazole necroptosis inhibitors. Bioorg Med Chem Lett. 2007 Dec 15;17(24):6836-40.

Title: Takahashi N, et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 2012 Nov 29;3:e437.

Title: Jagtap PG, Degterev A, Choi S, Structure-activity relationship study of tricyclic necroptosis inhibitors. J Med Chem. 2007 Apr 19;50(8):1886-95.

Title: Teng X, Degterev A, Jagtap P, Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett. 2005 Nov 15;15(22):5039-44.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:852391-20-9 Molecular Formula|852391-20-9 MDL|852391-20-9 SMILES|852391-20-9 Necrostatin 2 S-Enantiomer
Catalog No.: AA00G3ML
852391-20-9,MFCD26960959
852391-20-9 | Necrostatin 2 S-Enantiomer
Pack Size: 1mg
Purity: 99%
1 week
$162.00 $113.00
Pack Size: 5mg
Purity: 99%
1 week
$352.00 $247.00
Pack Size: 10mg
Purity: 99%
1 week
$543.00 $380.00
Pack Size: 50mg
Purity: 99%
1 week
$1,320.00 $924.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00G3ML
Chemical Name: Necrostatin 2 S-Enantiomer
CAS Number: 852391-20-9
Molecular Formula: C13H12ClN3O2
Molecular Weight: 277.7063
MDL Number: MFCD26960959
SMILES: CN1C(=O)[C@@H](NC1=O)Cc1c[nH]c2c1cccc2Cl
Properties
Complexity: 403  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 19  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.9  
Literature fold

Title: Structure-activity relationship study of novel necroptosis inhibitors.

Journal: Bioorganic & medicinal chemistry letters20051115

Title: Teng X, Keys H, Jeevanandam A, Structure-activity relationship study of ,2,3thiadiazole necroptosis inhibitors. Bioorg Med Chem Lett. 2007 Dec 15;17(24):6836-40.

Title: Takahashi N, et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 2012 Nov 29;3:e437.

Title: Jagtap PG, Degterev A, Choi S, Structure-activity relationship study of tricyclic necroptosis inhibitors. J Med Chem. 2007 Apr 19;50(8):1886-95.

Title: Teng X, Degterev A, Jagtap P, Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett. 2005 Nov 15;15(22):5039-44.

Building Blocks More >
851175-91-2
851175-91-2
3-Amino-4-(dimethylamino)benzenesulfonamide
AA00G3QZ | MFCD06373467
847759-02-8
847759-02-8
1-((2,5-Difluorophenyl)sulfonyl)piperidine-4-carboxylic acid
AA00G3V2 | MFCD07313708
75002-98-1
75002-98-1
2-Bromo-6-chlorobenzyl bromide
AA00G43Y | MFCD04038394
856213-49-5
856213-49-5
1-(2-Hydroxyethyl)piperidine-3-carboxylic acid
AA00G4EV | MFCD12169840
7659-03-2
7659-03-2
5-(1-Methylpiperidin-4-yl)-1,3,4-oxadiazol-2-amine
AA00G4K0 | MFCD12198480
74801-06-2
74801-06-2
1,2,3-Tri-O-benzyl-b-D-galactopyranoside
AA00G4R5 | MFCD07367689
7517-36-4
7517-36-4
MONOCYCLOHEXYLPHTHALATE
AA00G4Y6 | MFCD00517722
844639-06-1
844639-06-1
O-TriphenylMethoxy Quetiapine
AA00G54S | MFCD22200799
77746-54-4
77746-54-4
1-(4-Methylphenyl)-3-phenyl-1h-pyrazol-5-amine
AA00G5IV | MFCD00589678
80896-74-8
80896-74-8
trans-1-Benzyl-4-(4-chlorophenyl)pyrrolidine-3-carboxylic acid
AA00G666 | MFCD12755532
Submit
© 2017 AA BLOCKS, INC. All rights reserved.